ID :
103141
Thu, 01/28/2010 - 15:15
Auther :
Shortlink :
https://oananews.org//node/103141
The shortlink copeid
Dubai Health Authority unveils first facility in UAE that will help revolutionise diagnosis of cancer
Dubai, Jan 28, 2010 (WAM)- The Director General of the Dubai Health Authority yesterday inaugurated the first facility in the UAE that shall help significantly improve cancer management for patients in the UAE and the region.
The state-of-the-art facility is a factory which will manufacture an injection, which is required for patients who need to undergo PET (Positron Emission Tomography) scan.
The injection has a short shelf life of only 10 hours and therefore importing it into UAE was a cumbersome process. Now, the Dhs80m factory, that will manufacture this injection is set up in Dubai and the project is a joint venture with the Al Mulla Group and MONROL UAE.
The injection that is manufactured at this factory is known as the FDG (Flurodeoxglucose) which is a small radioactive glucose which is required for the PET scan. The PET scan is known to be much better than regular scans because it can detect cancer early, it can also detect the recurrence of cancer and it can identify if the treatment given to the patient is working within the first cycle of chemotherapy itself.
However, to conduct a PET scan, the patient needs to be injected with a dose of FDG, which with the establishment of this factory, will be locally manufactured, thus encouraging both private sector and public sector hospitals to equip themselves with the PET scan.
The main benefit of the PET scan is that it can detect cancer and its recurrence and this facilitates better survival rates of patients suffering from cancer.
Dr Jamila Salem Al Suwaidi, Consultant Medical Physicist in Nuclear Medicine at the Dubai Hospital attended the inauguration ceremony that took place this morning.
The state-of-the-art facility is a factory which will manufacture an injection, which is required for patients who need to undergo PET (Positron Emission Tomography) scan.
The injection has a short shelf life of only 10 hours and therefore importing it into UAE was a cumbersome process. Now, the Dhs80m factory, that will manufacture this injection is set up in Dubai and the project is a joint venture with the Al Mulla Group and MONROL UAE.
The injection that is manufactured at this factory is known as the FDG (Flurodeoxglucose) which is a small radioactive glucose which is required for the PET scan. The PET scan is known to be much better than regular scans because it can detect cancer early, it can also detect the recurrence of cancer and it can identify if the treatment given to the patient is working within the first cycle of chemotherapy itself.
However, to conduct a PET scan, the patient needs to be injected with a dose of FDG, which with the establishment of this factory, will be locally manufactured, thus encouraging both private sector and public sector hospitals to equip themselves with the PET scan.
The main benefit of the PET scan is that it can detect cancer and its recurrence and this facilitates better survival rates of patients suffering from cancer.
Dr Jamila Salem Al Suwaidi, Consultant Medical Physicist in Nuclear Medicine at the Dubai Hospital attended the inauguration ceremony that took place this morning.
